Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 393

1.

Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus.

Balabanian K, Couderc J, Bouchet-Delbos L, Amara A, Berrebi D, Foussat A, Baleux F, Portier A, Durand-Gasselin I, Coffman RL, Galanaud P, Peuchmaur M, Emilie D.

J Immunol. 2003 Mar 15;170(6):3392-400.

2.

Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and B-lymphocyte chemoattractant.

Balabanian K, Foussat A, Bouchet-Delbos L, Couderc J, Krzysiek R, Amara A, Baleux F, Portier A, Galanaud P, Emilie D.

Blood. 2002 Jan 15;99(2):427-36.

3.
6.

Functional dissection of lupus susceptibility loci on the New Zealand black mouse chromosome 1: evidence for independent genetic loci affecting T and B cell activation.

Wither JE, Lajoie G, Heinrichs S, Cai YC, Chang N, Ciofani A, Cheung YH, MacLeod R.

J Immunol. 2003 Aug 15;171(4):1697-706.

8.
9.

Production of stromal cell-derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal B lymphocytes.

Foussat A, Balabanian K, Amara A, Bouchet-Delbos L, Durand-Gasselin I, Baleux F, Couderc J, Galanaud P, Emilie D.

Eur J Immunol. 2001 Feb;31(2):350-9.

10.

Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.

Haas KM, Watanabe R, Matsushita T, Nakashima H, Ishiura N, Okochi H, Fujimoto M, Tedder TF.

J Immunol. 2010 May 1;184(9):4789-800. doi: 10.4049/jimmunol.0902391. Epub 2010 Apr 5.

11.

Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule.

Nakajima A, Azuma M, Kodera S, Nuriya S, Terashi A, Abe M, Hirose S, Shirai T, Yagita H, Okumura K.

Eur J Immunol. 1995 Nov;25(11):3060-9.

PMID:
7489744
13.

Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus.

Ito T, Ishikawa S, Sato T, Akadegawa K, Yurino H, Kitabatake M, Hontsu S, Ezaki T, Kimura H, Matsushima K.

J Immunol. 2004 Mar 15;172(6):3628-34.

14.

Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice.

Lawman S, Mauri C, Jury EC, Cook HT, Ehrenstein MR.

J Immunol. 2004 Dec 15;173(12):7641-6.

15.
16.

Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.

Liang B, Gardner DB, Griswold DE, Bugelski PJ, Song XY.

Immunology. 2006 Nov;119(3):296-305.

17.

Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF/BLyS production.

Postól E, Meyer A, Cardillo F, de Alencar R, Pessina D, Nihei J, Mariano M, Mengel J.

Immunology. 2008 Oct;125(2):184-96. doi: 10.1111/j.1365-2567.2008.02835.x. Epub 2008 Apr 7.

18.

Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice.

Zeng D, Lee MK, Tung J, Brendolan A, Strober S.

J Immunol. 2000 May 15;164(10):5000-4.

19.

Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.

Pau E, Chang NH, Loh C, Lajoie G, Wither JE.

Clin Immunol. 2011 May;139(2):215-27. doi: 10.1016/j.clim.2011.02.005. Epub 2011 Mar 17.

PMID:
21414847
20.

B cell apoptosis accelerates the onset of murine lupus.

Trébéden-Nègre H, Weill B, Fournier C, Batteux F.

Eur J Immunol. 2003 Jun;33(6):1603-12.

Supplemental Content

Support Center